OtherInflammation and Immunopharmacology
INHIBITION OF p38 MAPK PREVENTS INFLAMMATORY BONE DESTRUCTION
Gabriel Mbalaviele, Gary D. Anderson, Amy L. Jones, Pam De Ciechi, Steve L. Settle, Steve J. Mnich, Mark A. Thiede, Yousef Abu-Amer, Joseph Portanova and Joseph B. Monahan
Journal of Pharmacology and Experimental Therapeutics February 24, 2006, DOI: https://doi.org/10.1124/jpet.105.100362
Gabriel Mbalaviele
Gary D. Anderson
Amy L. Jones
Pam De Ciechi
Steve L. Settle
Steve J. Mnich
Mark A. Thiede
Yousef Abu-Amer
Joseph Portanova


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherInflammation and Immunopharmacology
INHIBITION OF p38 MAPK PREVENTS INFLAMMATORY BONE DESTRUCTION
Gabriel Mbalaviele, Gary D. Anderson, Amy L. Jones, Pam De Ciechi, Steve L. Settle, Steve J. Mnich, Mark A. Thiede, Yousef Abu-Amer, Joseph Portanova and Joseph B. Monahan
Journal of Pharmacology and Experimental Therapeutics February 24, 2006, DOI: https://doi.org/10.1124/jpet.105.100362
OtherInflammation and Immunopharmacology
INHIBITION OF p38 MAPK PREVENTS INFLAMMATORY BONE DESTRUCTION
Gabriel Mbalaviele, Gary D. Anderson, Amy L. Jones, Pam De Ciechi, Steve L. Settle, Steve J. Mnich, Mark A. Thiede, Yousef Abu-Amer, Joseph Portanova and Joseph B. Monahan
Journal of Pharmacology and Experimental Therapeutics February 24, 2006, DOI: https://doi.org/10.1124/jpet.105.100362
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement